Can a systemic infection cause bradycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Systemic Infection Cause Bradycardia?

Yes, systemic infections can definitively cause bradycardia, and this should be recognized as a reversible cause that requires treatment of the underlying infection rather than permanent pacing.

Evidence-Based Framework

The 2018 ACC/AHA/HRS Bradycardia Guidelines explicitly recognize reversible causes of bradycardia and mandate that patients presenting with symptomatic bradycardia secondary to a reversible cause should first be managed by directing therapy at eliminating or mitigating the offending condition (Class I recommendation) 1. While the guidelines don't specifically enumerate all infections, they establish the critical principle that reversible physiological disturbances must be identified and treated before considering permanent interventions.

Specific Infections Associated with Bradycardia

Relative Bradycardia Pattern

Several systemic infections characteristically produce "relative bradycardia" - an inappropriately low heart rate relative to fever:

  • Typhoid fever (P = 0.003)
  • Legionnaire's disease (P = 0.005)
  • Chlamydia pneumonia (P = 0.0005)

These infections share a common feature: they are caused by organisms that are both Gram-negative and intracellular 2. This pattern appears specific to these pathogens and does not occur with other Gram-negative extracellular infections, mycoplasma pneumonia, or viral infections 2.

COVID-19 and Bradyarrhythmias

COVID-19 represents a particularly important contemporary cause:

  • Bradycardia is a commonly reported complication of SARS-CoV-2 infection 3
  • Can manifest as transient sinus bradycardia or complete atrioventricular block 3
  • Some patients initially requiring permanent pacemakers experienced spontaneous conversion to sinus rhythm, suggesting the bradycardia was infection-related rather than permanent conduction disease 3
  • The mechanism likely involves complex systemic inflammatory responses 3, 4

Other Documented Infections

  • Brucella melitensis has been documented to cause relative bradycardia 5
  • The phenomenon appears across various systemic infections, though not universally

Clinical Implications and Management Algorithm

Initial Approach

  1. Identify the infection: Look specifically for typhoid fever, Legionnaire's disease, Chlamydia pneumonia, COVID-19, or brucellosis when bradycardia accompanies systemic infection
  2. Treat the underlying infection first: This is the Class I recommendation from guidelines 1
  3. Avoid premature permanent pacing: The guidelines explicitly state that permanent pacing should not be performed for reversible causes

Monitoring Strategy

For COVID-19 specifically, cardiac monitoring, hemodynamic evaluation, and strategy for permanent pacemaker should be treated on a case-by-case basis 3. Some patients with complete heart block may spontaneously convert, so temporary pacing with observation is reasonable before committing to permanent devices.

Critical Pitfall to Avoid

Do not implant a permanent pacemaker during active systemic infection causing bradycardia. The guidelines emphasize that permanent pacing has no clinical benefit when bradycardia is due to reversible causes 1, and premature device implantation exposes patients to:

  • Procedural complications and mortality risk
  • Long-term lead management implications
  • Unnecessary device burden if the bradycardia resolves with infection treatment

Prognostic Consideration

Interestingly, in septic shock specifically, relative bradycardia (heart rate <80 bpm) is associated with lower 28-day mortality (21% vs 34%, p<0.001) compared to tachycardic patients, even after adjusting for confounders 6. This suggests that bradycardia in systemic infection may not always indicate worse outcomes and reinforces the importance of treating the infection rather than reflexively treating the heart rate.

Bottom Line

Systemic infections are established reversible causes of bradycardia that mandate treatment of the underlying infection as the primary intervention 1. Specific pathogens (particularly intracellular Gram-negative organisms and COVID-19) have well-documented associations with bradycardia 5, 3, 4, 2. Permanent pacing should be deferred until the infection resolves and bradycardia persists, as many cases will spontaneously resolve with appropriate antimicrobial therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.